Logo image
Development of an ultrasound sensitive oxygen carrier for oxygen delivery to hypoxic tissue
Journal article   Open access   Peer reviewed

Development of an ultrasound sensitive oxygen carrier for oxygen delivery to hypoxic tissue

John R. Eisenbrey, Lorenzo Albala, Michael R. Kramer, Nick Daroshefski, David Brown, Ji-Bin Liu, Maria Stanczak, Patrick O’Kane, Flemming Forsberg and Margaret A. Wheatley
International journal of pharmaceutics, v 478(1), pp 361-367
18 Nov 2014
PMID: 25448552
url
https://europepmc.org/articles/pmc6457456View
Accepted (AM) Open

Abstract

Microbubble Oxygen delivery Surfactant Tumor hypoxia Ultrasound contrast agent
Radiation therapy is frequently used in the treatment of malignancies, but tumors are often more resistant than the surrounding normal tissue to radiation effects, because the tumor microenvironment is hypoxic. This manuscript details the fabrication and characterization of an ultrasound-sensitive, injectable oxygen microbubble platform (SE61 O2 ) for overcoming tumor hypoxia. SE61 O2 was fabricated by first sonicating a mixture of Span 60 and water-soluble vitamin E purged with perfluorocarbon gas. SE61 O2 microbubbles were separated from the foam by flotation, then freeze dried under vacuum to remove all perfluorocarbon, and reconstituted with oxygen. Visually, SE61 O2 microbubbles were smooth, spherical, with an average diameter of 3.1 μm and were reconstituted to a concentration of 6.5 E7 microbubbles/ml. Oxygen-filled SE61 O2 provides 16.9 ± 1.0 dB of enhancement at a dose of 880 μl/l (5.7 E7 microbubbles/l) with a half-life under insonation of approximately 15min. In in vitro release experiments, 2 ml of SE61 O2 (1.3 E8 microbubbles) triggered with ultrasound was found to elevate oxygen partial pressures of 100 ml of degassed saline 13.8 mmHg more than untriggered bubbles and 20.6 mmHg more than ultrasound triggered nitrogen-filled bubbles. In preliminary in vivo delivery experiments, triggered SE61 O2 resulted in a 30.4 mmHg and 27.4 mmHg increase in oxygen partial pressures in two breast tumor mouse xenografts.

Metrics

8 Record Views
72 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Pharmacology & Pharmacy
Logo image